Switching to bedaquiline for treatment of rifampicin-resistant tuberculosis in South Africa: A retrospective cohort analysis

South Africa led the world with guidelines on bedaquiline (BDQ) use as a single drug substitution to manage rifampin resistant tuberculosis regimen toxicity. We examined reasons for giving BDQ in a retrospective cohort: >75% of patients were switched to BDQ for toxicity (ototoxicity or renal dysf...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:PLoS One
Egile Nagusiak: Bouton, Tara C., de Vos, Margaretha, Ragan, Elizabeth J., White, Laura F., Van Zyl, Leonie, Theron, Danie, Horsburgh, C. Robert, Warren, Robin M., Jacobson, Karen R.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2019
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6797261/
https://ncbi.nlm.nih.gov/pubmed/31622366
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0223308
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak